We have been here before. Some news on copaxone would help a little. The "slam dunk" seems to be out of our playbook.
It is tough to score in this league when you only play defense. Let's see if our lawyers in the patent court are a little better than the guys who wrote the profit sharing on Enox.
unfourtunatly they(lawyers) evaluated and hired by the same people, who still head Momenta.